The World Health Organization has launched the SARS-CoV-2 Omicron variant assays and animal models study tracker.
The tracker compiles information that will facilitate matching those who have materials for Omicron-related studies with those who need them. The WHO’s research and development blueprint working groups on covid-19 assays and animal models met on 29 November to discuss action plans and knowledge about the emerging SARS-CoV-2 Omicron variant of concern first identified in South Africa’s Gauteng province.
There is an urgent need to evaluate the cross-reactivity, transmissibility, and pathogenicity of the Omicron variant because of multiple mutations in the SARS-CoV-2 spike protein, the apex UN health agency has realized.
Source: www.who.int
No comments:
Post a Comment